SAN FRANCISCO — As lab test startup Theranos Inc.’s woes multiply with a wave of class action lawsuits, board member David Boies is showing no sign of reducing his firm’s role as chief defender of the company.
In filings in federal court here Wednesday, three Washington-based attorneys for Boies, Schiller & Flexner entered appearances on behalf of Theranos in a proposed class action suit that alleges the company misled consumers about the reliability of its blood testing technology.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
